Studying saliva-based, asymptomatic testing to limit the spread of COVID-19
Share this story

Testing saliva samples of every Canadian on a routine basis could help decrease COVID-19 infections, sickness and deaths.

Researchers at McMaster University are studying the saliva-based testing procedures that would enable this on a large scale. They are developing high-capacity testing procedures—which could be done in university labs—to enable large-scale testing of asymptomatic people to better identify cases, isolate infected individuals and limit the virus’s spread.

The goal is to gain a better understanding of how to produce saliva-based tests on a commercial scale, the logistics involved in using them and how testing might impact workplaces such as universities, industry and long-term care homes.

For more information, visit McMaster University.

“Amica is proud to be a part of this important study. Saliva-based testing allows us to identify and isolate asymptomatic cases early – helping to mitigate the spread of COVID-19. This protects our team members and the seniors who call Amica home.”
Doug MacLatchy
CEO of Amica Senior Lifestyles, which has partially funded the study, together with McMaster’s Juravinski Research Institute
More Stories
OCAD University’s Centre for Emerging Artists and Designers
Producing headbands for medical face shields
Creating “street survival kits” to support vulnerable community members